Diabetic Nephropathy Latest Advances
Find the Latest Research About Diabetic Nephropathy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 40036 publications
Pharmacokinetics of novel drugs for the treatment of Diabetic nephropathy.
Journal: Expert opinion on drug metabolism & toxicology
Published: September 08, 2026
Retraction: Ma et al. Qi-dan-di-huang decoction alleviates diabetic nephropathy by inhibiting the NF-kappaB pathway. Frontiers in Bioscience (Landmark Edition). 2019; 24: 1477-1486.
Journal: Frontiers in bioscience (Landmark edition)
Published: September 03, 2026
The Ferroptosis-Immunity Axis in Diabetic Kidney Disease: Emerging Therapeutic Targets.
Journal: Antioxidants & redox signaling
Published: September 02, 2026
Protective association of the ELMO1 rs741301 variant against diabetes mellitus and diabetic nephropathy: a systematic meta-analysis of case-control studies.
Journal: Annals of human biology
Published: September 02, 2026
Association of serum fibroblast growth factor 19 with DKD as assessed by the UACR and eGFR in patients with type 2 diabetes.
Journal: Endocrine research
Published: September 01, 2026
Associations of life's crucial 9 and its components with all-cause and cardiovascular mortality in diabetic kidney disease patients.
Journal: Clinical nephrology
Published: August 31, 2026
Retraction notice to "Probucol ameliorates renal injury in diabetic nephropathy by inhibiting the expression of the redox enzyme p66Shc" [Redox Biol. 13 (2017) 482-497].
Journal: Redox biology
Published: August 27, 2026
Dismissing the Chaperone in the Diabetic Kidney.
Journal: Journal of the American Society of Nephrology : JASN
Published: August 27, 2026
Retraction notice to "Corrigendum to 'Probucol ameliorates renal injury in diabetic nephropathy by inhibiting the expression of the redox enzyme p66Shc'" [Redox Biology 26 (2019) 101276].
Journal: Redox biology
Published: August 27, 2026
Natural products modulate renal metabolic reprogramming in diabetic kidney disease.
Journal: Journal of translational internal medicine
Published: August 27, 2026
A covalent organic framework-based fluorescent immunosensor for selective NGAL detection enabling diabetic kidney disease stratification.
Journal: Chemical communications (Cambridge, England)
Published: August 24, 2026
Emerging therapies for diabetic kidney disease: beyond SGLT2 inhibitors.
Journal: Expert opinion on pharmacotherapy
Published: August 24, 2026
Last Updated: 09/26/2026